HPM Partners »

Oric Pharmaceuticals shares owned by HPM Partners

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by HPM Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $120k 11k 10.83

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
Procter & Gamble Company (PG)
Eli Lilly & Co. (LLY)

View all positions for HPM Partners

Top funds holding Oric Pharmaceuticals

Nextech Invest
BlackRock
EcoR1 Capital
T. Rowe Price Associates
Viking Global Investors
Sr One Capital Management
VR Adviser
NEA Management Company
Vanguard Capital Management
AIHC Capital Management
Alkeon Capital Management
State Street Corporation
Column Group
Siren
FMR

View all funds holding Oric Pharmaceuticals